Monday, January 23, 2017

UPDATE 3-Actelion drug setback unlikely to derail J&J talks - analysts

* Shares pare losses after falling more than 1 pct

(Releads, adds analyst reactions, updates shares)

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)